SEE: Earnings: Quality Means Everything
Another Soft Quarter
Fiscal fourth quarter results didn't show much of any improvement for business at Sysco. In fact, core volume and margin trends continue to be weak relative to Street expectations, and it's unclear to me that management has the ability to drive significant near-term changes.
Revenue rose 5% for the quarter, but underlying performance was quite a bit softer than that. Case volume did grow nearly 1% on an organic basis, about 1% better than the fiscal third quarter. Still, excluding food cost inflation (up 2%) and acquired revenue (up 2% net of forex), core growth was quite weak.
Top 5 Oil Service Stocks To Invest In 2015: Edwards Lifesciences Corporation (EW)
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products, which are used to replace or repair a patient�s diseased or defective heart valve; and produces pericardial and porcine valves. Its surgical heart valve therapy products include Carpentier-Edwards PERIMOUNT pericardial valve that comprise PERIMOUNT Magna Ease valves for aortic and mitral replacement; ThruPort systems that enable minimal incision valve surgery; and protection cannulae used during cardiac surgery in venous drainage, aortic perfusion, venting, and cardioplegia delivery. The company also provides transcatheter heart valves portfolio that includes technologies designed to treat heart valve disease using catheter-based approaches, as well as critical care products, such as hemodynamic monitoring systems to measure a p atient�s heart function in surgical and intensive care settings; Swan-Ganz line of pulmonary artery catheters and PreSep continuous venous oximetry catheters for measuring central venous oxygen saturation; VolumeView sensor-catheters; FloTrac continuous cardiac output monitoring system, a minimally invasive cardiac monitoring technology for goal-directed fluid optimization; and EV1000 clinical monitoring platform, which displays a patient's physiologic status. Its critical care products also include disposable pressure monitoring devices and closed blood sampling systems to help protect both patients and clinicians from the risk of infection; and products used to treat endolumenal occlusive disease, including balloon-tipped, catheter-based embolectomy products, surgical clips, and clamps. The company distributes its products through direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, Californi a.
Advisors' Opinion:- [By Teresa Rivas]
Shares of Edward Lifesciences (EW) were climbing as high as 15% in Monday morning trading, after a federal court late Friday sided with the firm in its patent infringement lawsuit against Medtronic�(MDT). The decision stipulated an injunction against the sale of Medtronic�� Transcatheter valves, although the firm plans to appeal the ruling. (Medtronic, by contrast, was falling 4.2%.)
Analysts were weighing in on the decision today. Canaccord Genuity�� Jason Mills and Jeffery Chu reiterated a Buy rating and $84 price target on the stock, calling the court victory surprising and important:
While we believe EW has a better chance than we previously thought of being granted a permanent injunction against MDT, we still expect EW to ultimately cash in via other forms of equitable relief in lieu of a final injunction: (1) lump-sum future damages; and (2) continuing royalties. Importantly, none of these potential outcomes are factored into our forward model.
What�� more, EW will have at least one more shot at winning further concessions from MDT, as EW filed a motion seeking a permanent injunction against MDT following a mid-January finding that MDT willfully infringed EW�� Cribier TAVR patent. A jury awarded EW $393M at that time in this case. We had expected this award to be tied up in appeals for several years; however, EW could use its increased leverage to push MDT to pay sooner.
Stifel Nicolaus�� Robert Wise and his team were more cautiously positively: While maintaining a Buy rating and $75 price target on the stock, they note that they don�� want to adjust their numbers, as the saga of appeals and counterappeals will likely drag on through the court system for some time (although, if upheld, they note that Friday�� victory would help Edward LIfesciences maintain greater-than-expected market share).
Their thoughts on the two names:
MDT Next Steps: Seeking Emergency Stay and Decision Appeal.Medtronic will see
- [By Ben Levisohn]
Yes, there are still more than two hours left in the day, but it’s New Year’s Eve and unless something crazy happens these five stocks look to be the worst of the worst in the S&P 500 in 2013. So let’s raise a big hand for Newmont Mining (NEM), Cliff’s Natural Resources (CLF) Edwards Lifesciences (EW), Peabody Energy (BTU) and Teradata (TDC).
Hot Quality Companies To Buy For 2014: Smith & Nephew SNATS Inc.(SNN)
Smith & Nephew plc develops, manufactures, markets, and sells medical devices in the orthopaedics, endoscopy, and advanced wound management sectors worldwide. The company operates in three segments: Orthopaedics, Endoscopy, and Advanced Wound Management. The Orthopaedics segment offers reconstruction implants, including hip, knee, and shoulder joints, as well as ancillary products, such as bone cement and mixing systems used in cemented reconstruction joint surgery. This segment also provides trauma fixation products consisting of internal and external devices, and other products, including shoulder fixation and orthobiological materials used in the stabilization of fractures and deformity correction procedures; and clinical therapies products comprising bone growth stimulation, joint fluid therapies, and outpatient spine products. The Endoscopy segment develops and commercializes minimally invasive surgery techniques, educational programs, and value-added services for sur geons to treat and repair soft tissue and articulating joints. It offers specialized devices and fixation systems to repair damaged tissues; fluid management equipment for surgical access; digital cameras, digital image capture, scopes, light sources, and monitors to assist with visualisation; radiofrequency wands, electromechanical and mechanical blades, and hand instruments for resecting damaged tissues. The Advanced Wound Management segment provides initial wound bed preparation and full wound closure products. This segment?s products are targeted at chronic wounds associated with the older population, such as pressure sores and venous leg ulcers; and products for the treatment of wounds, including burns and invasive surgery. The company serves medical and surgical service providers. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.
Advisors' Opinion:- [By Sean Williams]
Smith & Nephew (NYSE: SNN ) : 2.6% projected forward yield
Smith & Nephew is a U.K.-based medical-device maker that targets orthopedic reconstructive implants such as hip and knee replacements, and advanced wound management care products such as Durafiber and Acticoat for infection prevention. In the most recent quarter, Smith & Nephew delivered double-digit emerging-market growth (something my Foolish colleague Dan Carroll recently pointed out), while weak European growth caused sales in that region to be flat. Its sports medicine segment also delivered solid growth of 6%. - [By James Brumley]
All that being said, while St. Jude Medical might have never been known as a device pioneer, the acquisitions of Nanostim and Endosense have given STJ stock holders some exposure to pacemakers without pesky leads (where the “pulse” is created), and exposure to atrial fibrillation treatment without the use of drugs. This year might mark a serious upgrade for the company’s product lines.
Medical Devices: Smith & Nephew plc (SNN)Priced at a trailing P/E of 24 and a forward-looking P/E of 17, it’s not like you can call Smith & Nephew plc (SNN) a screaming value. It’s a reliable growth machine, however, in terms of earnings as well as revenue.
- [By Ben Levisohn]
St. Jude Medical gained 2.5% to $65.76 after said it would buy the portion of CardioMEMS that it did not already own following the approval of the latter’s heart-failure monitor. Stryker rose 2.8% to $82.64 after the company denied that it was planning a bid for Smith & Nephew (SNN). Smith & Nephew has advanced 3.3% to $83.05.
Hot Quality Companies To Buy For 2014: Qiwi PLC (QIWI)
QIWI plc., incorporated on February 26, 2007, is a provider of payment services in Russia and Commonwealth of Independent States (CIS). The Company has an integrated network that enables payment services across physical, online and mobile channels. In December 2013, the Company announced that it has completed the acquisition of Blestgroup Enterprises Limited.
The Company has deployed over 11 million virtual wallets, over 169,000 kiosks and terminals, and enabled over 40,000 merchants to accept cash and electronic payments monthly from over 65 million consumers using the Company 's network at least once a month. The Company�� consumers can use cash, stored value and other electronic payment methods to order and pay for goods and services across physical or online environments interchangeably.
Advisors' Opinion:- [By David Zeiler]
10. QIWI PLC (Nasdaq: QIWI): QIWI provides payment services to 65 million monthly customers in Russia as well as nations once part of the former Soviet Union. QIWI went public May 3 at an offer price of $17 and rose only 8 cents on its first day. Yet now QIWI trades at $40.95 - 140.88% higher than its IPO price.
- [By Steve Symington]
What:�Shares of QIWI PLC (NASDAQ: QIWI ) fell more than 16% Monday amid broader market unrest as Russia invaded Ukraine.�
So what:�The Moscow Exchange's Micex index fell nearly 11% on the day, so its unsurprising U.S.-listed Russian stocks like QIWI suffered the fallout. Shares of the Russia-based payment services provider are also still up more than 12% after a rapid rise over the past month, which at least partially explains the severity of today's drop.
- [By MONEYMORNING.COM]
On the other hand, I'll bet most people had never heard of two very different examples: Qiwi PLC (Nasdaq: QIWI) or, until our recent Money Morning coverage, GW Pharmaceuticals PLC-ADR (Nasdaq: GWPH), and that's too bad... or maybe not.
Hot Quality Companies To Buy For 2014: Deutsche Boerse AG (DB1)
Deutsche Boerse AG is a Germany-based international financial marketplace operator. It operates four business segments: Xetra; Eurex; Clearstream, and Market Data & Analytics. The Xetra business segment comprises three business areas: cash market using the Xetra electronic trading system and Xetra Frankfurt specialist trading; central counterparty for equities, and admission of securities to listing. The Eurex business segment comprises four business areas: electronic derivatives market trading platform Eurex; electronic options trading platform ISE; over-the-counter trading platforms Eurex Bonds, Eurex Repo, and Eurex Clearing. The Clearstream business segment comprises three business areas: custody, administration and settlement services for securities; global securities financing services, and investment funds services. The Market Data & Analytics business segment comprises two business areas: sales of price information and information distribution, and index development and sales. Advisors' Opinion:- [By Nikolaj Gammeltoft]
The mishap followed others earlier in the week. An Oct. 30 malfunction interrupted data transmission at Deutsche Boerse AG (DB1)�� International Securities Exchange, while Nasdaq was unable to distribute prices for its benchmark stock indexes for almost an hour on Oct. 29. The breakdowns refocused concern that the distribution of trading over dozens of mostly automated venues has made U.S. securities markets fundamentally flawed.
- [By Nikolaj Gammeltoft]
IntercontinentalExchange, the energy and commodity futures bourse known as ICE, is buying the U.S. equity exchange operator as the profitability of stock trading declines and derivatives generate more income. European Union regulators approved the deal on June 24 after blocking Deutsche Boerse AG (DB1)�� purchase of NYSE last year, citing concern over competition in derivatives and clearing.
- [By Jonathan Morgan]
QSC AG (QSC), a provider of telephony and data services to small and medium-sized businesses, jumped 9.5 percent after posting an increase in quarterly net income. Deutsche Boerse AG (DB1) retreated 2.7 percent after Equinet Bank AG downgraded the shares to sell.
Hot Quality Companies To Buy For 2014: CyrusOne Inc (CONE)
CyrusOne Inc., incorporated on July 31, 2012, is a owner, operator and developer of enterprise-class, carrier-neutral data center properties. Enterprise-class, carrier-neutral data centers are purpose-built facilities with redundant power, cooling and telecommunications systems and that are not network-specific, enabling customer interconnectivity to a range of telecommunications carriers. The Company provides mission-critical data center facilities that protect operation of information technology (IT) infrastructure for approximately 500 customers. As of September 30, 2012, its customers included nine of the Fortune 20 and 108 of the Fortune 1000 or private or foreign enterprises of equivalent size. On July 31, 2012, the Company�� operating partnership, CyrusOne LP, was formed. On July 31, 2012, CyrusOne GP, the general partner of the Company�� operating partnership, was formed as a trust.
As of September 30, 2012, the Company�� property portfolio included 23 operating data centers in nine markets: Austin, Chicago, Cincinnati, Dallas, Houston, London, San Antonio, Singapore, and South Bend providing approximately 1,630,000 net rentable square feet (NRSF) and powered by approximately 125 megawatts of utility power. The Company owns nine of the buildings in which its data center facilities are located. It leases the remaining 14 buildings, which account for approximately 600,000 NRSF. The Company also has 379,000 NRSF under development at three data centers in three markets (Dallas, Houston and Phoenix) and 762,000 NRSF of additional powered shell space under roof and available for development. In addition, it has approximately 146 acres of land that are available for future data center facility development. Along with its primary product offering, leasing of colocation space, its customers are interested in its ancillary office and other space.
As of September 2012, the Company added 36,000 Colocation Space (CSF) at its Westover Hills Blvd (San Antonio) facility, 47,0! 00 CSF at its Frankford Road (Carrollton) facility and 15,000 CSF at its Westway Park Blvd (Houston West) facility. The Company�� portfolio of properties consists primarily of data centers geographically concentrated in cities in Ohio and Texas, which comprised 38% and 59%, respectively, of its annualized rent as of September 30, 2012.
Advisors' Opinion:- [By Dan Caplinger]
But IBM has had to deal with increasing competition to its business model. Business software giant Oracle (NYSE: ORCL ) has finally reached an impressive execution milestone in the strategy it began four years ago with its acquisition of Sun Microsystems: Oracle's new chips and server products managed to best Big Blue's offerings in independent benchmark testing. Smaller companies will increasingly find their own niche roles in the big-data space as well. For instance, CyrusOne (NASDAQ: CONE ) , which got spun off from Cincinnati Bell recently, is seeking to make a name for itself in the data-storage infrastructure space. Despite its hefty debt load, CyrusOne has huge growth potential to capitalize on the growing need for data-storage centers, and it has the benefits of tax-favored real-estate investment trust status to boot.
- [By Ong Kang Wei]
For example, Digital Realty (DLR) is the undoubted leader in the data storage industry, with a market cap of $8.3B. Its other three competitors, DuPont Fabros (DFT), CoreSite Realty (COR) and CyrusOne (CONE), have market caps of $1.5B, $930M and $430M respectively. In addition, with the level of complexity involving Digital's business making it immensely difficult for companies to operate data centre facilities, the company is in a good position for future growth. The company also has a wide network of 595 tenants (significantly more than other competitors), including CenturyLink (CTL), AT&T and Morgan Stanley (MS). This further secures its long term business prospects and also its dominance over its competitors.
Hot Quality Companies To Buy For 2014: Cenkos Securities PLC (CNKS)
Cenkos Securities plc (Cenkos) is an independent, specialist institutional securities group, focused on growth companies and investment funds. The Company�� principal activities comprise of corporate broking and advisory and institutional equities. Corporate Broking and Advisory segment reflects the corporate finance, corporate broking and market making services provided to growth companies and investment funds. Institutional Equities segment reflects the institutional equities team who provide research-driven investment recommendations and execution capabilities to institutional clients. Cenkos earns fees from primary and secondary equity fund raising, acting as a key intermediary between growth companies or investment funds and institutional providers of capital. Revenue in Corporate Broking and Advisory segment is made up of placing commissions on fund raisings, corporate finance fees and retainer income, market making profits and commissions on secondary market transactions. Advisors' Opinion:- [By Trista Kelley]
Cenkos Securities Plc (CNKS) is running the spinoff and the share sale. Royal DSM NV (DSM), the world�� largest maker of vitamins, holds about 9 percent of SiS, while U.K. venture-capital trust Downing LLP owns 16.7 percent, Moon said. Provexis stockholders received one share of Science in Sport for every 100 shares of Provexis.
Hot Quality Companies To Buy For 2014: PowerSecure International Inc (POWR)
PowerSecure International, Inc. provides energy and smart grid solutions to electric utilities and their commercial, institutional, and industrial customers. The company?s products and services include Interactive Distributed Generation power systems, smart grid monitoring for electric utilities, peak shaving and demand response, and standby power dispatch and control products; and switchgear products and systems under the NexGear brand name. It also offers utility infrastructure products and services, including transmission and distribution system construction and maintenance under the UtilityServices brand name; engineering, regulatory consulting, and electric grid system design services under the UtilityEngineering and PowerServices brand names; LED lighting for grocery, drug, and convenience stores under the EfficientLights brand name; other LED-based lighting, including street lights; lighting and efficiency products for commercial and industrial customers under the E nergyLite brand name; and LED lighting and lighting components for OEMs and electronics manufacturers, as well as for commercial, industrial, and consumer lighting applications under the IES brand name. PowerSecure serves electric utilities, as well as commercial, institutional, and industrial customers in the United States, the Mid-Atlantic, the Midwest, and the Gulf Coast regions. The company was formerly known as Metretek Technologies, Inc. and changed its name to PowerSecure International, Inc. in August 2007. PowerSecure International, Inc. was founded in 1991 and is headquartered in Wake Forest, North Carolina.
Advisors' Opinion:- [By Monica Gerson]
PowerSecure International (NYSE: POWR) is estimated to post its Q4 earnings at $0.09 per share on revenue of $69.18 million.
CNinsure (NASDAQ: CISG) is projected to post its Q4 earnings at $0.10 per share.
- [By MONEYMORNING]
A good choice here is Power Secure International Inc. (Nasdaq: POWR).
Power Secure International is a leader in combining electricity distribution with enhanced infrastructure protections. POWR is up 43% since being introduced to Energy Inner Circle readers a little over eight months ago.
No comments:
Post a Comment